NPI: 1336245828 · AURORA, CO 80045 · Developmentally Disabled Services Day Training Agency · NPI assigned 09/15/2006
Authorized official MICHAEL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | MICHAEL, LINDA (VP, CHIEF COMPLIANCE OFFICER) |
| NPI Enumeration Date | 09/15/2006 |
Other providers sharing the same authorized official: MICHAEL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 292,963 | $25.74M |
| 2019 | 238,248 | $22.90M |
| 2020 | 153,229 | $15.07M |
| 2021 | 139,830 | $14.50M |
| 2022 | 116,523 | $14.16M |
| 2023 | 109,526 | $12.29M |
| 2024 | 94,183 | $10.24M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 124,387 | 117,343 | $37.34M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 41,456 | 39,158 | $10.67M |
| 41899 | Unlisted procedure, dentoalveolar structures | 2,628 | 2,409 | $6.22M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 3,401 | 3,044 | $4.70M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 23,456 | 8,431 | $4.63M |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 26,263 | 24,867 | $4.31M |
| 95782 | 1,663 | 1,575 | $2.51M | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 15,399 | 14,664 | $2.47M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 42,956 | 18,182 | $2.28M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 8,599 | 8,283 | $2.15M |
| 97803 | 12,307 | 11,261 | $2.14M | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 6,175 | 5,798 | $1.94M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 10,952 | 10,115 | $1.57M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 34,122 | 13,390 | $1.41M |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 9,403 | 8,970 | $1.41M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 2,922 | 2,739 | $1.30M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10,483 | 9,945 | $1.15M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 27,230 | 25,468 | $972K |
| J0475 | Injection, baclofen, 10 mg | 1,000 | 915 | $971K |
| 92609 | 5,264 | 2,099 | $969K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1,624 | 1,537 | $912K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 23,456 | 22,300 | $865K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 5,526 | 5,250 | $783K |
| 92508 | Group treatment of speech, language, voice, communication, and/or auditory processing disorder | 7,497 | 2,774 | $768K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13,209 | 12,223 | $700K |
| 76770 | 2,413 | 2,274 | $683K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2,354 | 2,269 | $668K |
| 93325 | 4,723 | 4,226 | $649K | |
| 96125 | 860 | 438 | $635K | |
| 96118 | 709 | 532 | $577K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9,547 | 8,924 | $549K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,574 | 3,487 | $540K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 192,039 | 176,484 | $491K |
| G0378 | Hospital observation service, per hour | 848 | 776 | $447K |
| 97802 | 1,720 | 1,648 | $428K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 29,512 | 22,492 | $422K |
| 92523 | 1,753 | 1,673 | $420K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9,547 | 8,924 | $405K |
| 94010 | 3,990 | 3,745 | $386K | |
| 80053 | Comprehensive metabolic panel | 9,786 | 7,318 | $382K |
| 97535 | Self-care/home management training, each 15 minutes | 4,160 | 1,999 | $360K |
| 81025 | 4,454 | 4,188 | $358K | |
| 97161 | 5,108 | 4,799 | $343K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 6,285 | 6,039 | $318K |
| 11900 | 609 | 580 | $292K | |
| 92526 | 1,778 | 826 | $292K | |
| 74018 | 3,310 | 2,507 | $288K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6,556 | 5,746 | $286K |
| 36415 | Collection of venous blood by venipuncture | 31,372 | 27,198 | $283K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 10,854 | 9,853 | $270K |
| 97760 | 5,727 | 3,941 | $263K | |
| 51798 | 1,764 | 1,660 | $263K | |
| 80197 | 2,923 | 1,838 | $245K | |
| 96132 | 270 | 233 | $232K | |
| 92587 | 1,162 | 1,103 | $217K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 81 | 81 | $212K |
| 94060 | 1,290 | 1,230 | $180K | |
| 97165 | 1,452 | 1,344 | $179K | |
| 95816 | 490 | 451 | $175K | |
| 99173 | 1,920 | 1,742 | $158K | |
| 81001 | 2,611 | 2,146 | $156K | |
| 99215 | Prolong outpt/office vis | 15,657 | 13,659 | $152K |
| 92551 | 3,335 | 3,087 | $152K | |
| 71046 | Radiologic examination, chest; 2 views | 1,397 | 1,211 | $150K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 112 | 107 | $145K |
| 97166 | 1,637 | 1,530 | $143K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,512 | 1,420 | $141K |
| 92610 | 798 | 736 | $140K | |
| 93225 | 1,485 | 1,407 | $136K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 52 | 50 | $134K |
| 90686 | 2,905 | 2,684 | $130K | |
| 99499 | 251 | 107 | $125K | |
| 72082 | 912 | 852 | $123K | |
| J3490 | Unclassified drugs | 21,335 | 11,756 | $122K |
| 96116 | 189 | 172 | $118K | |
| 82728 | 6,267 | 5,411 | $116K | |
| 95012 | 1,552 | 1,480 | $115K | |
| D9223 | Deep sedation/general anesthesia - each subsequent 15 minute increment | 150 | 150 | $113K |
| 97162 | 1,850 | 1,706 | $112K | |
| 80069 | 3,141 | 2,499 | $112K | |
| 84510 | 1,915 | 1,263 | $112K | |
| 95811 | 72 | 68 | $111K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 160 | 130 | $107K |
| 91300 | 7,308 | 6,316 | $103K | |
| 0002A | 4,177 | 3,820 | $102K | |
| 93226 | 1,485 | 1,407 | $92K | |
| 96156 | 531 | 468 | $90K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 5,286 | 2,878 | $90K |
| 90378 | 87 | 75 | $89K | |
| 96040 | 1,679 | 1,561 | $88K | |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 194 | 24 | $87K |
| 96000 | 197 | 184 | $83K | |
| 93320 | 3,055 | 2,863 | $79K | |
| 51736 | 888 | 844 | $79K | |
| 80076 | 1,691 | 1,513 | $79K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3,345 | 1,690 | $78K |
| 0001A | 3,131 | 2,884 | $76K | |
| 96133 | 345 | 284 | $71K | |
| 80061 | Lipid panel | 2,047 | 1,883 | $66K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 58,557 | 54,027 | $64K |
| 87631 | 445 | 434 | $59K | |
| 70360 | 373 | 363 | $59K | |
| 83735 | 2,519 | 1,702 | $56K | |
| 62370 | 268 | 245 | $50K | |
| 85046 | 5,950 | 5,055 | $49K | |
| 84030 | 1,917 | 1,263 | $48K | |
| 94621 | 145 | 134 | $44K | |
| 54161 | 14 | 13 | $44K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14,192 | 13,405 | $43K |
| 17110 | 199 | 185 | $42K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,229 | 2,939 | $41K |
| 73140 | 443 | 380 | $39K | |
| 92585 | 88 | 83 | $39K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 169 | 157 | $39K |
| 95819 | 117 | 115 | $38K | |
| 90837 | Psychotherapy, 53 minutes with patient | 290 | 133 | $37K |
| 31575 | 81 | 81 | $36K | |
| 93296 | 481 | 466 | $35K | |
| 36430 | 165 | 140 | $34K | |
| 84443 | Thyroid stimulating hormone (TSH) | 3,157 | 2,321 | $32K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 6,935 | 6,222 | $31K |
| 31622 | 15 | 13 | $31K | |
| 90791 | Psychiatric diagnostic evaluation | 106 | 97 | $30K |
| 91200 | 106 | 98 | $30K | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 6,829 | 6,596 | $30K |
| 72081 | 182 | 169 | $29K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1,705 | 1,615 | $28K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 87 | 80 | $28K |
| 51741 | 74 | 67 | $27K | |
| J2704 | Injection, propofol, 10 mg | 11,231 | 8,205 | $27K |
| 29075 | 146 | 138 | $27K | |
| 77072 | 166 | 157 | $27K | |
| 74230 | 165 | 152 | $26K | |
| 96136 | 192 | 174 | $26K | |
| 93271 | 91 | 83 | $25K | |
| 83655 | 409 | 397 | $25K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 3,347 | 1,149 | $25K |
| 95076 | 103 | 71 | $25K | |
| 82977 | 3,276 | 2,468 | $23K | |
| 80320 | 127 | 119 | $22K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 193 | 77 | $22K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 29 | 24 | $20K |
| 0296T | 251 | 235 | $20K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 7,778 | 7,022 | $20K |
| 96158 | 339 | 161 | $20K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 25 | 25 | $19K |
| 82610 | 639 | 598 | $19K | |
| 87799 | 502 | 385 | $19K | |
| 83970 | 564 | 485 | $18K | |
| 90474 | 869 | 826 | $18K | |
| 96137 | 162 | 154 | $17K | |
| 95079 | 85 | 42 | $17K | |
| 72170 | 197 | 196 | $17K | |
| 84436 | 1,286 | 918 | $17K | |
| 86140 | 983 | 919 | $16K | |
| J8540 | Dexamethasone, oral, 0.25 mg | 361 | 244 | $15K |
| 95715 | 12 | 12 | $15K | |
| 0297T | 251 | 235 | $15K | |
| 97164 | 310 | 281 | $14K | |
| 82784 | 841 | 402 | $14K | |
| 82570 | 850 | 635 | $14K | |
| 97763 | 337 | 223 | $14K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 100 | 93 | $14K |
| 99201 | 13,822 | 13,453 | $13K | |
| 90834 | Psychotherapy, 45 minutes with patient | 156 | 78 | $13K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,324 | 3,644 | $13K |
| 83516 | 852 | 280 | $13K | |
| 92524 | 139 | 127 | $13K | |
| 91307 | 784 | 732 | $12K | |
| 86850 | 442 | 347 | $12K | |
| 92567 | 1,828 | 1,689 | $12K | |
| 95991 | 204 | 180 | $11K | |
| 87536 | 98 | 78 | $11K | |
| 96409 | 55 | 49 | $11K | |
| 85027 | 587 | 554 | $11K | |
| 64642 | 55 | 55 | $10K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 111 | 106 | $10K |
| 0071A | 420 | 418 | $10K | |
| 96167 | 1,484 | 1,328 | $10K | |
| 97799 | 879 | 526 | $9K | |
| 77073 | 77 | 77 | $9K | |
| 92579 | 342 | 325 | $9K | |
| 73521 | 70 | 68 | $9K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 358 | 346 | $9K |
| 73130 | 98 | 88 | $9K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1,354 | 1,250 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,065 | 2,759 | $9K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2,571 | 2,496 | $8K |
| 96119 | 30 | 27 | $8K | |
| 0072A | 336 | 334 | $8K | |
| 87497 | 210 | 160 | $8K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 154 | 154 | $8K |
| 85652 | 1,150 | 1,056 | $8K | |
| 92522 | 43 | 35 | $7K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 81 | 81 | $7K |
| 96152 | 44 | 28 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 176 | 164 | $6K |
| 62322 | 39 | 36 | $6K | |
| 90656 | 214 | 205 | $6K | |
| 20560 | 356 | 219 | $6K | |
| 93246 | 49 | 44 | $6K | |
| 81003 | 1,063 | 1,021 | $6K | |
| 86364 | 333 | 323 | $6K | |
| 96900 | 45 | 12 | $6K | |
| 87070 | 421 | 399 | $6K | |
| 87808 | 142 | 133 | $6K | |
| 86832 | 160 | 145 | $6K | |
| 73110 | 68 | 63 | $5K | |
| 92557 | 154 | 145 | $5K | |
| 86901 | 457 | 362 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 2,198 | 2,034 | $5K |
| 86900 | 458 | 362 | $5K | |
| 95951 | 13 | 12 | $5K | |
| 93247 | 49 | 44 | $5K | |
| 90715 | 28 | 28 | $5K | |
| 83540 | 558 | 349 | $5K | |
| 95700 | 12 | 12 | $4K | |
| 73100 | 30 | 24 | $4K | |
| 73560 | 35 | 28 | $4K | |
| V5020 | Conformity evaluation | 186 | 149 | $4K |
| 93270 | 42 | 41 | $4K | |
| 87081 | 522 | 486 | $4K | |
| 86592 | 282 | 269 | $4K | |
| 82248 | 179 | 129 | $4K | |
| 83550 | 555 | 346 | $4K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 944 | 695 | $4K |
| 73090 | 28 | 25 | $4K | |
| 84100 | 827 | 558 | $4K | |
| 31526 | 19 | 16 | $4K | |
| 96154 | 678 | 565 | $4K | |
| 84478 | 573 | 523 | $4K | |
| 83020 | 107 | 85 | $3K | |
| 93243 | 17 | 15 | $3K | |
| 85018 | 260 | 240 | $3K | |
| 86833 | 160 | 145 | $3K | |
| 84460 | 840 | 782 | $3K | |
| 43762 | 12 | 12 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 121 | 116 | $3K |
| 84403 | 94 | 82 | $3K | |
| 64615 | 15 | 12 | $3K | |
| 76825 | 29 | 26 | $3K | |
| 92555 | 168 | 162 | $3K | |
| 93242 | 17 | 15 | $3K | |
| 97750 | 68 | 67 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 27 | 27 | $3K |
| 73564 | 17 | 16 | $3K | |
| 87205 | 77 | 74 | $3K | |
| 92552 | 122 | 117 | $3K | |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 25 | 25 | $3K |
| 84305 | 296 | 165 | $3K | |
| 93356 | 150 | 136 | $3K | |
| 84270 | 41 | 38 | $3K | |
| 82785 | 90 | 88 | $3K | |
| 86003 | 77 | 75 | $3K | |
| 97116 | 85 | 45 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 36 | 30 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | 572 | 466 | $2K |
| 90480 | 93 | 92 | $2K | |
| 96138 | 14 | 13 | $2K | |
| 76885 | 12 | 12 | $2K | |
| 92060 | 255 | 250 | $2K | |
| 84156 | 300 | 267 | $2K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 21 | 13 | $2K |
| 92595 | 56 | 47 | $2K | |
| 92652 | 40 | 37 | $2K | |
| 92015 | Determination of refractive state | 594 | 401 | $2K |
| 84439 | 391 | 126 | $2K | |
| 87899 | 76 | 75 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | 201 | 100 | $2K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 15 | 13 | $2K |
| 91320 | 49 | 48 | $2K | |
| 0003A | 87 | 85 | $2K | |
| 96150 | 13 | 13 | $2K | |
| 82652 | 38 | 27 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 16 | 14 | $2K |
| 83520 | 136 | 64 | $2K | |
| 76827 | 29 | 26 | $2K | |
| 87486 | 27 | 27 | $2K | |
| J7050 | Infusion, normal saline solution, 250 cc | 431 | 259 | $2K |
| 87503 | 36 | 30 | $2K | |
| 86762 | 27 | 27 | $2K | |
| 81321 | 24 | 24 | $2K | |
| 92611 | 401 | 377 | $1K | |
| 81302 | 12 | 12 | $1K | |
| 83993 | 16 | 13 | $1K | |
| 87077 | 163 | 138 | $1K | |
| 69210 | 13 | 12 | $1K | |
| 92133 | 24 | 24 | $1K | |
| 0124A | 33 | 32 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,014 | 1,850 | $1K |
| 90911 | 648 | 296 | $1K | |
| 36416 | 2,282 | 1,906 | $1K | |
| 86923 | 28 | 24 | $1K | |
| D1120 | Prophylaxis - child | 24 | 24 | $1K |
| 98976 | 27 | 24 | $1K | |
| 90832 | Psychotherapy, 30 minutes with patient | 22 | 12 | $1K |
| L3030 | Foot, insert, removable, formed to patient foot, each | 646 | 556 | $1K |
| 85397 | 14 | 14 | $1K | |
| 87181 | 195 | 171 | $1K | |
| 92025 | 14 | 14 | $995.42 | |
| 86255 | 47 | 28 | $973.60 | |
| 87184 | 194 | 178 | $939.23 | |
| 81405 | 25 | 25 | $860.45 | |
| 81407 | 25 | 25 | $860.45 | |
| 76000 | 14 | 13 | $850.40 | |
| 64643 | 40 | 40 | $845.00 | |
| 90912 | 730 | 421 | $842.09 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 27 | 27 | $832.78 |
| 96155 | 163 | 146 | $812.80 | |
| 81406 | 25 | 25 | $798.98 | |
| 85610 | 80 | 63 | $796.74 | |
| 84402 | 41 | 38 | $795.24 | |
| D1206 | Topical application of fluoride varnish | 24 | 24 | $792.00 |
| 81408 | 25 | 25 | $768.25 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 27 | 27 | $749.32 |
| 87581 | 27 | 27 | $749.32 | |
| 81404 | 24 | 24 | $737.52 | |
| 92591 | 14 | 12 | $717.53 | |
| 82542 | 12 | 12 | $700.37 | |
| V5011 | Fitting/orientation/checking of hearing aid | 35 | 32 | $633.28 |
| 80047 | 13 | 12 | $608.92 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 42 | 38 | $607.32 |
| 86376 | 113 | 43 | $605.48 | |
| 92582 | 227 | 220 | $604.27 | |
| 91312 | 33 | 32 | $576.53 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 221 | 210 | $551.70 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 47 | 43 | $525.64 |
| D0120 | Periodic oral evaluation - established patient | 15 | 15 | $510.00 |
| 87071 | 15 | 12 | $505.68 | |
| 85014 | 43 | 33 | $495.00 | |
| 87340 | 28 | 28 | $493.86 | |
| 86902 | 92 | 83 | $479.79 | |
| 82272 | 105 | 102 | $469.79 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 44 | 31 | $461.64 |
| 96002 | 123 | 116 | $448.04 | |
| 92556 | 91 | 89 | $409.75 | |
| 82950 | 51 | 51 | $371.13 | |
| 83615 | 55 | 39 | $333.79 | |
| J9370 | Vincristine sulfate, 1 mg | 102 | 91 | $282.55 |
| 96168 | 255 | 211 | $246.47 | |
| 85240 | 14 | 14 | $237.75 | |
| 86920 | 94 | 85 | $231.54 | |
| 90913 | 401 | 247 | $221.60 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 242 | 238 | $196.80 |
| 89051 | 15 | 12 | $194.04 | |
| 86677 | 14 | 12 | $169.84 | |
| 84450 | 48 | 44 | $135.98 | |
| J3535 | Drug administered through a metered dose inhaler | 116 | 112 | $135.11 |
| 86800 | 66 | 16 | $127.94 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 13 | 13 | $112.65 |
| 82340 | 32 | 25 | $104.98 | |
| 96164 | 70 | 55 | $97.37 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 13 | 12 | $89.94 |
| 88108 | 27 | 24 | $86.38 | |
| 36591 | 29 | 25 | $84.02 | |
| 82043 | 61 | 16 | $76.64 | |
| V5266 | Battery for use in hearing device | 393 | 363 | $65.70 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 143 | 91 | $51.68 |
| J1170 | Injection, hydromorphone, up to 4 mg | 58 | 50 | $46.38 |
| 82947 | 14 | 14 | $43.50 | |
| A4364 | Adhesive, liquid or equal, any type, per oz | 56 | 50 | $39.56 |
| 96165 | 51 | 42 | $26.95 | |
| 82803 | 26 | 24 | $25.40 | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | 188 | 186 | $6.75 |
| 96159 | 219 | 113 | $0.00 | |
| V5257 | Hearing aid, digital, monaural, bte | 153 | 115 | $0.00 |
| L1832 | Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 28 | 28 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 14 | 12 | $0.00 |
| C1769 | Guide wire | 14 | 12 | $0.00 |
| V5264 | Ear mold/insert, not disposable, any type | 154 | 101 | $0.00 |
| 96171 | 14 | 13 | $0.00 | |
| 86803 | 12 | 12 | $0.00 | |
| 96170 | 29 | 28 | $0.00 | |
| 96139 | 14 | 13 | $0.00 | |
| 96151 | 28 | 28 | $0.00 | |
| J9250 | Methotrexate sodium, 5 mg | 15 | 12 | $0.00 |